Kristen Hayashi is a Senior Director at Healthsperien specializing in prescription drug policy, delivery system reform, and value-based care. At Healthsperien, she leads research and strategy focused on the financing and coverage of high-cost therapies, from cell and gene therapies to GLP-1 medications, and the implications of evolving drug policies for health care costs and patient access. Her work combines rigorous data analysis with qualitative research to translate complex policy questions into actionable, evidence-based insights for decision-makers. Before joining Healthsperien, Kristen held research, policy, and analytic roles at NORC at the University of Chicago, MassHealth, and Harvard Law School’s Center for Health Law and Policy Innovation.